14-day Premium Trial Subscription Try For FreeTry Free

Recap: Rockwell Medical Q1 Earnings

04:32pm, Monday, 17'th May 2021
Shares of Rockwell Medical (NASDAQ:RMTI) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 33.33% year over year to ($0.08), which beat
-Home Infusion FPC Program expected to initiate Phase 2 trial in second half of 2021-
Rockwell Medical (RMTI) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
WIXOM, Mich., April 22, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q4 2020 Results - Earnings Call Transcript
Rockwell Medical (RMTI) delivered earnings and revenue surprises of -12.50% and -5.34%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical: Q4 Earnings Insights

04:29pm, Wednesday, 31'st Mar 2021
Shares of Rockwell Medical (NASDAQ:RMTI) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 18.18% year over year to ($0.09), which m

Rockwell Medical's Earnings: A Preview

10:06am, Tuesday, 30'th Mar 2021
On Wednesday, March 31, Rockwell Medical (NASDAQ:RMTI) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.
Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors need to pay close attention to Rockwell Medical (RMTI) stock based on the movements in the options market lately.
WIXOM, Mich., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and
>82,000 patients receiving hemodialysis annually >82,000 patients receiving hemodialysis annually
Rockwell Medical (RMTI) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
China is a sizable and growing market, with more than 600,000 patients receiving hemodialysis annually China is a sizable and growing market, with more than 600,000 patients receiving hemodialysis ann
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE